Although inhibiting integrin adhesion or FAK/PYK2 signaling significantly diminished leukemia burden and prolonged survival in a mouse model of T-ALL, the mice eventually succumbed to leukemia, suggesting other cell-intrinsic pathways or supportive elements of the TME would need to be inhibited simultaneously for therapeutic intervention. Here, PTK2B is linked to leukemia.